The largest database of trusted experimental protocols

Epirubicin hydrochloride

Manufactured by Pfizer
Sourced in United States

Epirubicin hydrochloride is a cytotoxic anthracycline antibiotic. It is used as a chemotherapeutic agent.

Automatically generated - may contain errors

3 protocols using epirubicin hydrochloride

1

TACE Protocol for Hepatocellular Carcinoma

Check if the same lab product or an alternative is used in the 5 most similar protocols
In the a-TACE group, conventional TACE was performed 4–6 weeks after surgery based on the patient’s liver function and performance status, and the specific steps were implemented according to the previously described technique.24 (link) In brief, a catheter was inserted into the hepatic artery through the femoral artery using Seldinger technique for hepatic artery angiography, and 200 mg/m2 Carboplatin (Carboplatin, Bristol-Myers Squibb, New York, NY, USA) and 6 mg/m2 mitomycin (Mitomycin, Hisun, Taizhou, China) were administered followed by injection of 4–5 mL of iodized oil emulsion (lipiodol, Andre Guerbet, Aulnay-sous-Bois, France) and 40 mg/m2 epirubicin hydrochloride (epirubicin hydrochloride, Pfizer, New York, NY, USA). These patients underwent comprehensive evaluation including physical examination, routine blood analysis and CT scan approximately one month later. The second cycle of TACE or HAIC was performed according to the decision of investigators based on the patients’ conditions and the assessment results.
+ Open protocol
+ Expand
2

Cytotoxicity Evaluation of Anticancer Drugs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Clinical-grade (NCI Dictionary of Cancer Terms, http://www.cancer.gov/dictionary), pirarubicin (Pi, Wanle, Shenzhen) paclitaxel (Pa, Taiji, Sichuan), Adriamycin (Ad, Pfizer, Jiangsu), epirubicin hydrochloride (EH, Haizheng, Zhejiang), and cisplatin (Ci, Haosen, Jiangsu) were used. Relative IC50 values were determined as previously described [21 (link)].
+ Open protocol
+ Expand
3

TACE after Hepatectomy for Liver Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
The patients in the Hepatectomy-TACE group underwent TACE 4–6 weeks after hepatectomy according to liver function and performance status. TACE was performed using the techniques we have described previously [24 (link)]. In brief, a catheter was placed into the proper hepatic artery through the femoral artery using the Seldinger technique, hepatic arterial angiography was performed, and 200 mg/m2 Carboplatin (Carboplatin, Bristol-Myers Squibb, New York, NY, USA) and 6 mg/m2 mitomycin (Mitomycin, Hisun, Taizhou, China) were infused followed by 4–5 mL of the emulsion of iodized oil (lipiodol, Andre Guerbet, Aulnay-sous-Bois, France) and 40 mg/m2 epirubicin (Epirubicin Hydrochloride, ‎Pfizer, New York, NY, USA). After 4–6 weeks, these patients underwent a complete assessment consisting of physical examination, routine blood analysis, and CT scan. The second cycle of TACE was performed according to the decision of investigators based on the patients’ conditions and the assessment results.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!